MITO

Stealth BioTherapeutics Corp. ADS

Delisted

MITO was delisted on the 15th of November, 2022.

13 hedge funds and large institutions have $1.46M invested in Stealth BioTherapeutics Corp. ADS in 2020 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+3
Holders Change %
+30%
% of All Funds
0.23%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
3
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
Renaissance Technologies
1
Renaissance Technologies
New York
$849K +$716K +478,903 +537%
BBHC
2
Brown Brothers Harriman & Co
New York
$262K
Mercer Global Advisors
3
Mercer Global Advisors
Colorado
$75K +$75K +50,000 New
VF
4
Virtu Financial
New York
$67K +$67K +44,337 New
IC
5
Ikarian Capital
Texas
$57K
Citadel Advisors
6
Citadel Advisors
Florida
$50K +$31.9K +21,446 +176%
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$41K +$41K +27,282 New
TSS
8
Two Sigma Securities
New York
$22K +$22K +14,851 New
Goldman Sachs
9
Goldman Sachs
New York
$22K +$22K +14,989 New
Morgan Stanley
10
Morgan Stanley
New York
$9K
SFS
11
Sowell Financial Services
Arkansas
$4K +$4K +2,939 New
UBS Group
12
UBS Group
Switzerland
$1K -$10.4K -7,115 -91%
Osaic Holdings
13
Osaic Holdings
Arizona
$1K +$276 +230 +38%
PM
14
Prosight Management
Texas
-$346K -256,044 Closed
HF
15
HRT Financial
New York
-$23K -17,092 Closed